Stifel lowered the firm’s price target on Indivior (INDV) to 1,100 GBp from 1,400 GBp and keeps a Buy rating on the shares.Discover the Best ...

Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks for 2025.

Rhumbline Advisers trimmed its holdings in shares of Stifel Financial Corp. (NYSE:SF – Free Report) by 2.8% during the fourth ...

Stifel lowered the firm’s price target on Carrefour (CRRFY) to EUR 16.50 from EUR 18 and keeps a Buy rating on the shares.Discover the Best ...

While the scope of U.S.-imposed tariffs continues to expand, their impact on the economy remains uncertain, according to economists Lindsey Piegza and Lauren Henderson of Stifel, Nicolaus & Co. in ...

DraftKings (NASDAQ:DKNG – Get Free Report) had its target price raised by equities research analysts at Stifel Nicolaus from ...

ST. LOUIS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.36 billion for the three months ended December 31, 2024, compared with $1.15 ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...

ST. LOUIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth ...

With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), ...